MUC13 protects colorectal cancer cells from death by activating the NF-kappa B pathway and is a potential therapeutic target
YH Sheng, Y He, SZ Hasnain, R Wang, H Tong, DT Clarke, R Lourie, I Oancea, KY Wong, JW Lumley, TH Florin, P Sutton, JD Hooper, NA McMillan, MA McGuckin
Oncogene | NATURE PUBLISHING GROUP | Published : 2017
Awarded by Australian National Health and Medical Research Council (NHMRC)
This work was supported by the Australian National Health and Medical Research Council (NHMRC) project grant 1060698 and by funding from the Mater Foundation. MAM is supported by an NHMRC Principal Research Fellowship. The Translational Research Institute (TRI) is supported by a grant from the Australian Government. We acknowledge the technical assistance of the TRI core facilities for flow cytometry, microscopy and biological resources. We thank Michael R Tallack for help with Chip analysis and John Silke for providing feedback on our manuscript.